• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BRE
Click for more information
0.33% $3.06

BRAZILIAN RARE EARTHS LIMITED - Corporate Spotlight

Market Cap $211.6M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Brazilian Rare Earths Limited is a mineral exploration company focused on the discovery... Brazilian Rare Earths Limited is a mineral exploration company focused on the discovery and development of critical mineral resources. Its segments include Brazil exploration and Corporate. Its Rocha da Rocha Project (the project) comprises of 96 granted exploration permits; one application for an exploration permit; four applications for mining permits; two disponibilidades, and an option to acquire a further three granted exploration permits. The granted exploration permits within the project cover a total combined area of 140,988 hectares (ha) (1,410 square kilometer (km)) in the Rocha da Rocha Critical Minerals Province, located in Bahia, Brazil. The Project is a large-scale greenfields discovery of rare-earth elements (REE) mineralization that includes high-grade REE-Nb-Sc mineralization, saprolite monazite enriched mineralization, and ionic clay style REE mineralization. The project is also prospective for niobium, scandium, uranium, bauxite, and other critical minerals.More

No Corporate Spotlight currently available.

(20min delay)
Last
$3.06 		Change
0.010(0.33%) 		Mkt cap ! $211.6M
Open High Low Value Volume
$3.05 $3.24 $3.05 $246.9K 78.38K

Buyers (Bids)

No. Vol. Price($)
1 959 $3.06
 

Sellers (Offers)

Price($) Vol. No.
$3.18 409 1
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
$3.11 		  Change
0.010 ( 0.00 %)
Open High Low Volume
$3.09 $3.19 $3.09 5292
Last updated 15.59pm 10/05/2024 ?
BRE (ASX) Chart

Top Stories

Tamboran is listing on the NYSE, and Wall Street is paying attention

If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.
Recce breathes better on positive lung infection drug pilot test results Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
Raiden opens door to private Mallina in win-win Arrow Gold divestment Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.
UNITH's digital humans expand into Amazon; Facebook AI-powered 'Digital Human' chatbot developer UNITH has announced its in-house tech can now harmonise with that used by Facebook and Amazon.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.